Kyowa Kirin Co., Ltd. (KYKOF)
OTCMKTS
· Delayed Price · Currency is USD
14.75
0.00 (0.00%)
At close: Apr 11, 2025
Kyowa Kirin Employees
Kyowa Kirin had 5,669 employees as of December 31, 2024. The number of employees decreased by 305 or -5.11% compared to the previous year.
Employees
5,669
Change (1Y)
-305
Growth (1Y)
-5.11%
Revenue / Employee
$556,007
Profits / Employee
$67,173
Market Cap
7.99B
Employees Chart
Employees History
Related Stocks
Company Name | Employees |
---|---|
Endo Inc. | 3,116 |
Glass House Brands | 374 |
Elite Pharmaceuticals | 64 |
Northwest Biotherapeutics | 25 |
CytoDyn | 9 |
American Oncology Network | 1,914 |
Silence Therapeutics | 116 |
Longduoduo Company | 49 |
Kyowa Kirin News
- 7 weeks ago - Amgen Inc (AMGN) and Kyowa Kirin Announce Promising Phase 3 Results for Rocatinlimab in Atopic ... - GuruFocus
- 2 months ago - Kyowa Kirin Announces Late-Breaking Abstract Presentation at the American Academy of Dermatology Annual Meeting 2025 - PRNewsWire
- 2 months ago - Kura Oncology Cancer Study Hits Primary Goal, Lays Out Plans For Phase 3 Studies - Benzinga
- 3 months ago - Kyowa Kirin and Swixx BioPharma announce expansion of access to POTELIGEO® (mogamulizumab) for adults living with mycosis fungoides or Sézary syndrome in Central and Eastern Europe - Business Wire
- 3 months ago - AlphaMeld Corporation Expands Collaboration with Kyowa Kirin for Enterprise-Wide Access to Drug Discovery Platform - GlobeNewsWire
- 4 months ago - Cimeio Therapeutics Announces Partnership with Kyowa Kirin to Develop Novel Cell Therapies - Business Wire
- 5 months ago - Kura stock slides 17% on Kyowa Kirin deal for ziftomenib - Seeking Alpha
- 5 months ago - Kura Oncology to partner with Kyowa Kirin for blood cancer therapy - Reuters